High-degree atrioventricular block complicating ST segment elevation myocardial infarction in the contemporary era

Autor: Philippe Castellant, Philippe Druelles, Bertrand Avez, Gilles Rouault, Marielle Le Guellec, Jean-Claude Daubert, Dominique Boulmier, Raphaël P. Martins, Jean Philippe Hacot, Aurélie Loirat, Régis Delaunay, Martine Gilard, Hervé Le Breton, Emmanuelle Filippi, Guillaume Leurent, Isabelle Coudert, Josiane Treuil, Vincent Auffret, Marc Bedossa, Antoine Rialan, B. Boulanger
Přispěvatelé: Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes], CHU Pontchaillou [Rennes], Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de cardiologie [Vannes], Centre hospitalier de Vannes, Optimisation des régulations physiologiques (ORPHY (EA 4324)), Université de Brest (UBO)-Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Service de cardiologie [Saint Malo], CH de Saint-Malo [Broussais], Service de cardiologie [Quimper], CH de Quimper, SAMU [Vannes], CHBA Vannes, SAMU [Brest], Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), CIC-IT Rennes, Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
medicine.medical_specialty
Time Factors
Myocardial Infarction
Myocardial Reperfusion
Kaplan-Meier Estimate
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
Reperfusion therapy
Risk Factors
Internal medicine
Odds Ratio
medicine
Humans
ST segment
Hospital Mortality
Registries
030212 general & internal medicine
Myocardial infarction
Atrioventricular Block
Aged
Proportional Hazards Models
Retrospective Studies
Aged
80 and over

Chi-Square Distribution
business.industry
Incidence
Cardiogenic shock
Mortality rate
Middle Aged
medicine.disease
3. Good health
Hospitalization
Logistic Models
Treatment Outcome
Multivariate Analysis
Cardiology
Platelet aggregation inhibitor
Myocardial infarction complications
Female
[SDV.IB]Life Sciences [q-bio]/Bioengineering
France
Myocardial infarction diagnosis
Cardiology and Cardiovascular Medicine
business
Platelet Aggregation Inhibitors
Zdroj: Heart
Heart, BMJ Publishing Group, 2016, 102 (1), pp.40--49. ⟨10.1136/heartjnl-2015-308260⟩
Heart, 2016, 102 (1), pp.40--49. ⟨10.1136/heartjnl-2015-308260⟩
ISSN: 1355-6037
1468-201X
Popis: International audience; Background High-degree atrioventricular block (HAVB) is a common complication of ST segment elevation myocardial infarction (STEMI). HAVB in STEMI is historically considered as a marker of worse outcome but overall data about HAVB in the contemporary era of mechanical reperfusion and potent antiplatelet therapies are scarce. Aim Analysing incidence, clinical correlates and impact on inhospital outcomes of HAVB in a large prospective registry (Observatoire Régional Breton sur l'Infarctus, ORBI) of modern management of STEMI with a special focus on potential differences between patients with HAVB on admission and those who developed HAVB during hospitalisation. Methods All patients enrolled in ORBI between June 2006 and December 2013 were included in the present analysis and were divided into 3 groups: patients without HAVB at any time, patients with HAVB on admission and those who developed HAVB during hospitalisation. Results A total of 6662 patients (age: 62.0 (52.0–74.0) years; male: 76.3%) were included in the present analysis. HAVB was documented in 3.5% of patients, present on admission in 63.7% of patients and occurring during hospitalisation in 36.3%. Patients with HAVB on admission or occurring during the first 24 h of hospitalisation had higher inhospital mortality rates (18.1% and 28.6%, respectively) than patients without (4.5%) or with HAVB occurring beyond the first 24 h of hospitalisation (8.0%). However by multivariable analysis, HAVB was not independently associated with inhospital mortality contrarily to age, presentation as cardiac arrest, anterior STEMI location, reperfusion therapy, cardiogenic shock, mechanical ventilation and occurrence of sustained ventricular tachyarrhythmias or mechanical complication. Conclusions Patients with HAVB had a higher mortality rate than patients without. However HAVB is not an independent predictor of inhospital mortality
Databáze: OpenAIRE